Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes
Norway

PMID:25066056  

Mutation of Nogo-B receptor, a subunit of cis-prenyltransferase, causes a congenital disorder of glycosylation.

Eon Joo Park | Kariona A Grabińska | Ziqiang Guan | Viktor Stránecký | Hana Hartmannová | Kateřina Hodaňová | Veronika Barešová | Jana Sovová | Levente Jozsef | Nina Ondrušková | Hana Hansíková | Tomáš Honzík | Jiří Zeman | Helena Hůlková | Rong Wen | Stanislav Kmoch | William C Sessa
Cell metabolism | 2014

Dolichol is an obligate carrier of glycans for N-linked protein glycosylation, O-mannosylation, and GPI anchor biosynthesis. cis-prenyltransferase (cis-PTase) is the first enzyme committed to the synthesis of dolichol. However, the proteins responsible for mammalian cis-PTase activity have not been delineated. Here we show that Nogo-B receptor (NgBR) is a subunit required for dolichol synthesis in yeast, mice, and man. Moreover, we describe a family with a congenital disorder of glycosylation caused by a loss of function mutation in the conserved C terminus of NgBR-R290H and show that fibroblasts isolated from patients exhibit reduced dolichol profiles and enhanced accumulation of free cholesterol identically to fibroblasts from mice lacking NgBR. Mutation of NgBR-R290H in man and orthologs in yeast proves the importance of this evolutionarily conserved residue for mammalian cis-PTase activity and function. Thus, these data provide a genetic basis for the essential role of NgBR in dolichol synthesis and protein glycosylation.

Pubmed ID: 25066056

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NHLBI NIH HHS, United States
    Id: P01 HL070295
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL61371
  • Agency: NIGMS NIH HHS, United States
    Id: U54 GM069338
  • Agency: NEI NIH HHS, United States
    Id: R01 EY023666
  • Agency: NHLBI NIH HHS, United States
    Id: R37 HL061371
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL096670
  • Agency: NHLBI NIH HHS, United States
    Id: P01 HL70295
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL081190
  • Agency: NHLBI NIH HHS, United States
    Id: R01HL64793
  • Agency: NIGMS NIH HHS, United States
    Id: T32 GM007324
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL064793
  • Agency: NIGMS NIH HHS, United States
    Id: GM-069338
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL061371

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Adobe Photoshop (tool)

RRID:SCR_014199

Software for image processing, analysis, and editing. The software includes features such as touch capabilities, a customizable toolbar, 2D and 3D image merging, and Cloud access and options.

View all literature mentions